Yes, it can be a bit obscure. Basically, what it means is that, if we cross-match using the raw plasma and we detect no reactions, or we cross-match using auto-adsorbed plasma, and we detect no reactions, then the blood is issued as "compatible with". If we cross-match using the raw plasma, in which we have detected a clinically insignificant antibody, such as anti-Kna, we cannot provide Kn(a-) blood, as so we will cross-match and choose the least incompatible, and issue it as "suitable for". If we cross-match using inhibited plasma, as in the case of anti-Ch or anti-Rg, we will also issue as "suitable for". If we cross-match using alloadsorbed plasma, and we detect no reactions, we issue the blood as "suitable for". The difference between the autoadsorbed plasma and the alloadsorbed plasma is that autoadsorption will leave behind an alloantibody directed against a high frequency antigen (such as an anti-Vel) - hence the "compatible with", whilst the alloadsorption will almost certainly take out an antibody directed against a high frequency antigen (again, such as anti-Vel) - hence the "suitable for". To put it another way, if we issue blood as "compatible with", we are pretty sure that there will be no adverse reactions, whereas if we issue blood as "suitable for" we are hoping that there will be no adverse reactions (but it is still, to a certain extent, an in vivo cross-match). I hope that helps to explain the difference. If not, get back to me. :)